126 related articles for article (PubMed ID: 12562860)
1. Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells.
Sniderman AD; Zhang Z; Genest J; Cianflone K
J Lipid Res; 2003 Mar; 44(3):527-32. PubMed ID: 12562860
[TBL] [Abstract][Full Text] [Related]
2. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
Avramoglu RK; Cianflone K; Sniderman AD
J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
[TBL] [Abstract][Full Text] [Related]
3. Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.
Peluso MR; Dixon JL
Lipids; 1997 Aug; 32(8):811-23. PubMed ID: 9270972
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver.
Tarugi P; Nicolini S; Ballarini G; Marchi L; Duvigneau C; Tartoni P; Calandra S
J Lipid Res; 1996 Mar; 37(3):493-507. PubMed ID: 8728313
[TBL] [Abstract][Full Text] [Related]
5. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages.
Langer C; Huang Y; Cullen P; Wiesenhütter B; Mahley RW; Assmann G; von Eckardstein A
J Mol Med (Berl); 2000; 78(4):217-27. PubMed ID: 10933584
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Borradaile NM; de Dreu LE; Barrett PH; Huff MW
J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells.
Dashti N; Franklin FA; Abrahamson DR
J Lipid Res; 1996 Apr; 37(4):810-24. PubMed ID: 8732781
[TBL] [Abstract][Full Text] [Related]
8. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
10. Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship.
Zhang Z; Cianflone K; Sniderman AD
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):743-52. PubMed ID: 10073982
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
Pau E; He Y; Lougheed M; Steinbrecher UP
Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
[TBL] [Abstract][Full Text] [Related]
12. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
Azuma Y; Kawasaki T; Ohno K; Seto J; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1999 Feb; 79(2):151-8. PubMed ID: 10202850
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Wilcox LJ; Barrett PH; Huff MW
J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
[TBL] [Abstract][Full Text] [Related]
14. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
Carr TP; Hamilton RL; Rudel LL
J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
[TBL] [Abstract][Full Text] [Related]
15. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
16. Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion.
Liza M; Chico Y; Fresnedo O; Ochoa B
Lipids; 2003 Jan; 38(1):53-63. PubMed ID: 12669820
[TBL] [Abstract][Full Text] [Related]
17. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
Dashti N
J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick.
Tarugi P; Nicolini S; Marchi L; Ballarini G; Calandra S
J Lipid Res; 1994 Nov; 35(11):2019-31. PubMed ID: 7868980
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid.
Theriault A; Wang Q; Van Iderstine SC; Chen B; Franke AA; Adeli K
J Lipid Res; 2000 Dec; 41(12):1969-79. PubMed ID: 11108730
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
Graham A; Wood JL; Russell LJ
Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]